Subtopic Deep Dive
Glaucoma Global Prevalence
Research Guide
What is Glaucoma Global Prevalence?
Glaucoma Global Prevalence estimates worldwide incidence, prevalence, and projections of glaucoma burden using population-based surveys and meta-analyses.
Quigley (2006) estimated 60.5 million people with glaucoma in 2010, rising to 79.6 million by 2020, with open-angle glaucoma predominant in most regions except angle-closure in Asians (7266 citations). Tham et al. (2014) projected 111.8 million cases by 2040, emphasizing regional variations and underdiagnosis (6573 citations). These meta-analyses aggregate data from over 50 population studies worldwide.
Why It Matters
Estimates from Quigley (2006) and Tham et al. (2014) guide public health screening programs, as glaucoma causes 8-10% of global blindness despite being asymptomatic early (Quigley 1996). Regional data highlight needs in Asia and among women, informing WHO blindness prevention strategies (Flaxman et al. 2017). Projections support resource allocation for aging populations, projecting 3-fold increase in US cases by 2020 (Friedman 2004; Congdon 2004).
Key Research Challenges
Heterogeneous Diagnostic Criteria
Studies use varying IOP thresholds and visual field definitions, complicating meta-analyses (Tham et al. 2014). Quigley (2006) notes inconsistencies across 50+ surveys. Standardization remains unresolved (Flaxman et al. 2017).
Underdiagnosis in Low-Resource Areas
Asymptomatic nature leads to 80-90% undiagnosed cases in Africa and Asia (Quigley 1996). Population surveys miss rural populations (Bourne et al. 2020). Projections underestimate true burden (Tham et al. 2014).
Projecting Aging Population Trends
Demographic shifts challenge 2040 forecasts amid rising life expectancy (Tham et al. 2014). Models overlook migration and comorbidity changes (Bourne et al. 2020). Validation against new census data needed (Quigley 2006).
Essential Papers
The number of people with glaucoma worldwide in 2010 and 2020
Harry A. Quigley · 2006 · British Journal of Ophthalmology · 7.3K citations
Glaucoma is the second leading cause of blindness worldwide, disproportionately affecting women and Asians.
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
Yih Chung Tham, Li Xiang, Tien Yin Wong et al. · 2014 · Ophthalmology · 6.6K citations
Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
Seth Flaxman, Rupert Bourne, Serge Resnikoff et al. · 2017 · The Lancet Global Health · 3.2K citations
Number of people with glaucoma worldwide.
H A Quigley · 1996 · British Journal of Ophthalmology · 3.0K citations
Glaucoma is the second leading cause of vision loss in the world. Improved methods of screening and therapy for glaucoma are urgently needed.
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
Nathan Congdon · 2004 · Archives of Ophthalmology · 2.6K citations
Blindness or low vision affects approximately 1 in 28 Americans older than 40 years. The specific causes of visual impairment, and especially blindness, vary greatly by race/ethnicity. The prevalen...
Optical coherence tomography angiography
Richard F. Spaide, James G. Fujimoto, Nadia K. Waheed et al. · 2017 · Progress in Retinal and Eye Research · 1.6K citations
Optical coherence tomography (OCT) was one of the biggest advances in ophthalmic imaging. Building on that platform, OCT angiography (OCTA) provides depth resolved images of blood flow in the retin...
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Ryan Lee, Tien Yin Wong, Charumathi Sabanayagam · 2015 · Eye and Vision · 1.5K citations
Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus worldwide, approximately one third have signs of DR and of these, a f...
Reading Guide
Foundational Papers
Start with Quigley (1996; 3040 citations) for baseline estimates, then Quigley (2006; 7266 citations) for 2010-2020 projections, and Tham et al. (2014; 6573 citations) for methods and 2040 forecasts.
Recent Advances
Bourne et al. (2020; 1227 citations) updates GBD trends over 30 years; Flaxman et al. (2017; 3244 citations) integrates glaucoma into global blindness causes.
Core Methods
Population-based surveys with standardized IOP/visual field exams; random-effects meta-analysis for pooling; age-standardized projections via demographic models.
How PapersFlow Helps You Research Glaucoma Global Prevalence
Discover & Search
Research Agent uses searchPapers('glaucoma global prevalence meta-analysis') to retrieve Quigley (2006) as top result with 7266 citations, then citationGraph to map forward citations to Tham et al. (2014) and Bourne et al. (2020), and findSimilarPapers for regional breakdowns.
Analyze & Verify
Analysis Agent applies readPaperContent on Thigley (2006) to extract prevalence tables, then runPythonAnalysis with pandas to recompute 2020 projections from raw data, verified by verifyResponse (CoVe) and GRADE scoring for meta-analysis quality (high confidence due to systematic review methods).
Synthesize & Write
Synthesis Agent detects gaps in African data via contradiction flagging between Quigley (1996) and recent GBD studies, then Writing Agent uses latexEditText to draft regional comparison tables, latexSyncCitations for 10+ papers, and latexCompile for a projection report with exportMermaid timelines.
Use Cases
"Extract prevalence rates by WHO region from top 5 glaucoma papers and plot trends."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib for bar charts of Quigley 2006 vs Tham 2014 rates) → CSV export of regional data.
"Write LaTeX section on glaucoma projections to 2040 with citations."
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (prevalence curves) → latexSyncCitations (Tham 2014, Bourne 2020) → latexCompile → PDF report.
"Find GitHub repos analyzing Global Burden of Disease glaucoma data."
Research Agent → paperExtractUrls (Flaxman 2017) → Code Discovery → paperFindGithubRepo → githubRepoInspect (Jupyter notebooks for GBD prevalence models) → runPythonAnalysis sandbox.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (50+ glaucoma epidemiology papers) → citationGraph clustering → DeepScan (7-step extraction of prevalence/ORs with GRADE checkpoints) → structured CSV report. Theorizer generates screening cost-models from Quigley/Tham projections: literature synthesis → hypothesis on regional thresholds → Python simulation. DeepScan verifies meta-analysis biases in Tham et al. (2014) via CoVe chains.
Frequently Asked Questions
What is the definition of Glaucoma Global Prevalence?
Glaucoma Global Prevalence compiles meta-analyses estimating worldwide cases, incidence rates, and projections from population surveys (Quigley 2006; Tham et al. 2014).
What methods estimate global glaucoma burden?
Meta-analyses pool visual field, IOP, and optic disc data from 50+ surveys, using random-effects models for prevalence and Markov simulations for projections to 2040 (Tham et al. 2014; Quigley 2006).
What are the key papers?
Quigley (2006; 7266 citations) estimates 79.6M cases by 2020; Tham et al. (2014; 6573 citations) projects 111.8M by 2040; Quigley (1996; 3040 citations) sets baseline at 50M cases.
What open problems exist?
Underdiagnosis in low-resource regions, inconsistent diagnostics, and updating projections for post-2020 demographics remain unresolved (Bourne et al. 2020; Friedman 2004).
Research Retinal Diseases and Treatments with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Glaucoma Global Prevalence with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Retinal Diseases and Treatments Research Guide